期刊文献+

参麦注射液雾化吸入防治急性放射性肺炎的临床效果 被引量:8

Clinnical value of prevention and treatment of acute radiation-induced pneumonitis by inhalation of senmai injection
下载PDF
导出
摘要 目的探讨参麦注射液雾化吸入在防治急性放射性肺炎中的作用。方法将2007年8月~2008年7月在该院治疗的局部晚期非小细胞肺癌患者60例,随机分成治疗组与对照组各30例,治疗组给予参麦注射液雾化吸入加同期化、放疗,对照组给予同期化、放疗,两组放疗方式及化疗方案相同。观察两组患者急性放射性肺炎开始出现的时间及反应程度。结果实验组患者开始出现放射性肺炎的时间明显晚于对照组,差异有显著性;实验组患者出现放射性肺炎的程度明显轻于对照组,差异有显著性。结论参麦注射液雾化吸入防治急性放射性肺炎疗效显著,使用方便,值得临床推广应用。 【Objective】To explore the clinical value of prevention and treatment of acute radiation-induced pneumonitis by inhalation of Senmai injection.【Methods】 Sixty patients with local advaced non-small-cell lung cancer from August 2007 through July 2008 in our hospital were assigned randomly into two groups: thirty patients in the treatment arm received inhalation of Senmai injection and concurrent chemoradiotherapy; thirty patients in the control arm received concurrent chemoradiotherapy.Two arms received the same chemoradiotherapy. The time acute radiation-induced pneumonitis occurred and sevevity of acute radiation-induced pneumonitis were observed and analysed. [Results] The time acute radiation-induced pneumonitis occurred in the treatment arm is later than in the control arm ; sevevity of acute radiation-induced pneumonitis in the treatment ann were smaller than in the control arm, the difference is significant statistically. [ Conclusion ] Inhalation of senmai injection is a useful and convinent way in the prevention and treatment of acute radiation-induced pneumonitis.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2009年第23期3604-3605,3609,共3页 China Journal of Modern Medicine
关键词 参麦注射液 雾化吸入 非小细胞性肺癌 急性放射性肺炎 同期化、放疗 Senmai injection inhalation non-small-cell lung cancer acute radiation-induced pneumonitis concurrent chemoradiotherapy
  • 相关文献

参考文献3

二级参考文献18

  • 1彭光明.肺辐射损伤的临床、病理及X线[J].实用放射学杂志,1995,11(11):688-689. 被引量:7
  • 2[1]Albrigt F, Rifenstem C. The parathyroid glands and metabolic bone disease. Baltimone: William and Wilkins Company, 1948.78.
  • 3[2]Herschberger LG, et al. Myotrophic activity of 19 nortestosterone and other steroids determined by the modified levator muscle method. Proc Soc Exp Biol Med,1953,83:175-180.
  • 4[3]Markiewisz L, Gurpide E. In vitro evaluation of estrogenic,estrogenic antagonistic effects of a steroidal drug (Org OD14)and its metabolites on human endometrium. J Steroid Biochem,1990,35:535-541.
  • 5[4]Rymer J, et al. Effect of tibolone on postmenopausal bone loss. Osteoporosis Int,1994,4:314-317.
  • 6[5]Gompel A, et al. The effect of tibolone on proliferation, differentiation and apoptosis in normal breast cells. Gynecol Endocrinol,1997,11(Suppl1):77-79.
  • 7[6]Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and HRT: collaborative reanalysis of data from 51 epidemiological studies of 52705 women with breast cancer and 108411 women without breast cancer. Lancet, 1997,350:1047-1059.
  • 8[7]Bjamason NH, et al. Tibolone: influence on markers of cardiovascular disease. J Clin Endocrinol Metab,1997,82:1752-1756.
  • 9[8]Haenggi W, et al. Long-term influence of different postmenopausal hormone replacemnt regimes on serum lipids and lipoprotein (a): a randomised study. Br J Obstet Gynaecol,1997,104:708-717.
  • 10[9]DeAloysic D, et al. Use of Org OD14 for the treatment of climacteric complaints. Maturitas,1987,(Supp 1):49-65.

共引文献58

同被引文献131

引证文献8

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部